Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Augmenting Clozapine With Sertindole: A Double-Blind, Randomized, Placebo-Controlled Study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. How to Estimate QT Interval in Patients With Left or Right Bundle Branch Block: A Systematic Review

    Research output: Contribution to journalReviewpeer-review

  2. Severe Parkinsonism and Creatine Kinase Increase After Low-Dose Aripiprazole Treatment in a Patient of African Descent

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Off-Label Prescription of Psychopharmacological Drugs in Child and Adolescent Psychiatry

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Postprandial prolactin suppression appears absent in antipsychotic-treated male patients

    Research output: Contribution to conferencePosterResearch

  3. Postprandial prolactin suppression appears absent in antipsychotic-treated male patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Glucometabolic Hormones and Cardiovascular Risk Markers in Antipsychotic-Treated Patients

    Research output: Contribution to journalConference abstract in journalResearch

View graph of relations
ABSTRACT: Clozapine augmentation with antipsychotic drugs is widely used despite sparse evidence supporting this strategy. Sertindole is a nonsedating atypical antipsychotic drug with low affinity for cholinergic receptors, which makes it potentially suitable for augmentation of clozapine. The study design was a 12-week, double-blind, randomized, placebo-controlled study including patients with International Statistical Classification of Diseases, 10th Revision schizophrenia (F20.0-F20.3) and treated with clozapine for at least 6 months who had not achieved sufficient response. Patients were randomized 1:1 to either sertindole 16 mg or placebo, and assessment was done at baseline and after 6 and 12 weeks. Assessment included the Positive and Negative Syndrome Scale, Clinical Global Impression, Udvalg for Kliniske Undersøgelser, World Health Organization Quality of Life Brief, Drug Attitude Inventory, fasting glucose, lipids, and electrocardiogram. Clozapine augmentation with sertindole was not superior to placebo regarding total score or subscale score of the Positive and Negative Syndrome Scale, Clinical Global Impression, World Health Organization Quality of Life Brief, or Drug Attitude Inventory. No increased adverse effects compared with placebo were found. Four patients randomized to sertindole experienced a significant worsening of psychosis, and 2 of them required psychiatric admission. Metabolic parameters were unchanged during the study, but augmentation of clozapine with sertindole was associated with a 12-millisecond (SD, 20-millisecond) QTc prolongation compared with 0 millisecond (SD, 20 milliseconds) in the placebo group (P <0.03). Augmentation with sertindole showed no benefits compared with placebo. Psychiatrists should be aware that augmentation might not add any benefits for the patients and in some cases worsen psychosis.
Original languageEnglish
JournalJournal of Clinical Psychopharmacology
Volume32
Issue number2
Pages (from-to)173-178
Number of pages6
ISSN0271-0749
DOIs
Publication statusPublished - 2012

ID: 34705046